Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Department of Pathology, Bergonié Institute, Bordeaux, France.
Am J Surg Pathol. 2022 Mar 1;46(3):363-375. doi: 10.1097/PAS.0000000000001829.
We report 27 solitary fibrous tumors of the female genital tract emphasizing nonvulvar locations, variant histology, and prognostic factors. The patients ranged from 25 to 78 years (most were over 40), and tumors occurred in the vulva (7), vagina (2), cervix (2), corpus (6), fallopian tube/paratubal soft tissue (5), and ovary (5). They ranged from 1.5 to 39 (mean=10.5) cm and were typically solid, but 4 were predominantly cystic. All had a haphazard arrangement of spindled to ovoid cells, with most demonstrating alternating cellular and hypocellular areas and prominent vessels, but 13 lacked hypocellular areas, and 7 had focal diffuse growth with inconspicuous vasculature. Other patterns included corded (8), fascicular (5), trabecular (1), and nested (1). Microcysts (6), myxoid background (8), hyalinization (8), lipomatous differentiation (2), and multinucleated cells (6) were also present, and 10 tumors had necrosis. Vasculature included thin-walled branching "staghorn" (27), thick-walled (7), and hyalinized vessels (5) or dilated anastomosing vascular channels (3). Nuclear atypia ranged from mild (19), moderate (7), to severe (1), and mitoses from 0 to 24/10 HPF (mean=4). STAT6 was positive in all 25 tumors tested. One tumor showed dedifferentiation; the remainder were classified as benign (19) or malignant (7) based on mitotic rate (univariate stratification model) and as low risk (14), intermediate risk (8), or high risk (4) based on the Demicco multivariate risk stratification score. Follow-up (median=23 mo) was available for 16 patients. Six tumors recurred (2 intermediate risk, 3 high risk, and the dedifferentiated tumor), 5 in the abdomen; the dedifferentiated tumor metastasized to the lung. Multivariate risk stratification was superior to univariate classification, as 5 "benign" tumors were reclassified as intermediate risk using the multivariate model; of these, 2 recurred, and 1 patient died of disease. Upper female genital tract tumors occurred in older patients, were larger, and more frequently classified as high risk compared with those of the lower tract. A trend toward increased cellularity was also seen in the upper tract tumors. Only size (P=0.04), necrosis (P=0.04), and Demicco score (P=0.01) independently correlated with recurrence. Female genital tract solitary fibrous tumors demonstrate a wide range of variant morphologies and occur in diverse sites in addition to the vulva. Tumors were often misdiagnosed as other neoplasms; thus, awareness of solitary fibrous tumors occurring at these sites is crucial in prompting staining for STAT6 to establish this diagnosis. The Demicco risk stratification system effectively predicts behavior.
我们报告了 27 例女性生殖道孤立性纤维瘤,强调非外阴部位、变异组织学和预后因素。患者年龄 25 至 78 岁(多数在 40 岁以上),肿瘤发生于外阴(7 例)、阴道(2 例)、宫颈(2 例)、子宫体(6 例)、输卵管/附件软组织结构(5 例)和卵巢(5 例)。肿瘤大小为 1.5 至 39cm(平均 10.5cm),通常为实性,但 4 例以囊性为主。所有肿瘤均由纺锤形至卵圆形细胞杂乱排列而成,大多数呈交替性细胞和细胞稀少区及显著血管,但 13 例缺乏细胞稀少区,7 例呈弥漫性生长伴不明显血管。其他形态包括条索状(8 例)、束状(5 例)、小梁状(1 例)和巢状(1 例)。微囊(6 例)、黏液样背景(8 例)、玻璃样变(8 例)、脂肪分化(2 例)和多核细胞(6 例)也存在,10 例肿瘤发生坏死。血管包括薄壁分支状“鹿角状”(27 例)、厚壁(7 例)和玻璃样变血管(5 例)或扩张吻合血管通道(3 例)。核异型性从轻度(19 例)、中度(7 例)到重度(1 例),有丝分裂从 0 至 24/10HPF(平均 4 个)。25 例检测的肿瘤均为 STAT6 阳性。1 例肿瘤发生去分化;其余肿瘤根据有丝分裂率(单因素分层模型)和 Demicco 多因素风险分层评分,分为良性(19 例)或恶性(7 例),低危(14 例)、中危(8 例)或高危(4 例)。16 例患者获得随访(中位随访 23 个月)。6 例肿瘤复发(2 例中危,3 例高危,1 例去分化肿瘤),5 例发生于腹部;去分化肿瘤转移至肺部。多因素风险分层优于单因素分类,5 例“良性”肿瘤采用多因素模型重新分类为中危;其中 2 例复发,1 例患者死于疾病。上生殖道肿瘤发生于老年患者,体积较大,且与下生殖道肿瘤相比,更常被归类为高危。上生殖道肿瘤的细胞丰富度也呈增加趋势。仅大小(P=0.04)、坏死(P=0.04)和 Demicco 评分(P=0.01)与复发独立相关。女性生殖道孤立性纤维瘤表现出广泛的变异形态,并发生于外阴以外的多种部位。肿瘤常被误诊为其他肿瘤;因此,在这些部位出现时意识到孤立性纤维瘤的存在,对于进行 STAT6 染色以确立这一诊断至关重要。Demicco 风险分层系统可有效预测肿瘤行为。